Projected Age-Based Prevalence and Management Cost of Chronic Hepatitis C-Induced Advanced Liver Disease in the United States

被引：0
|
作者：
Deniz, Baris [1 ]
Velez, Fulton [1 ]
Pyenson, Bruce [2 ]
Iwasaki, Kosuke [2 ]
机构：
[1] Vertex Pharmaceut Inc, Cambridge, MA USA
[2] Milliman Inc, New York, NY USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2010年 / 105卷
关键词：
D O I：
10.14309/00000434-201010001-01100
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1100
引用
收藏
页码：S399 / S399
页数：1
相关论文
共 50 条
  • [1] Population level outcomes and cost-effectiveness of expanding guidance for age-based hepatitis C testing in the United States
    Barocas, J. A.
    Tasillo, A.
    Yazdi, G. E.
    Wang, J.
    Vellozzi, C.
    Hariri, S.
    Isenhour, C.
    Randall, L.
    Salomon, J. A.
    Linas, B. P.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S491 - S491
  • [2] Population-level Outcomes and Cost-Effectiveness of Expanding the Recommendation for Age-based Hepatitis C Testing in the United States
    Barocas, Joshua A.
    Tasillo, Abriana
    Yazdi, Golnaz Eftekhari
    Wang, Jianing
    Vellozzi, Claudia
    Hariri, Susan
    Isenhour, Cheryl
    Randall, Liisa
    Ward, John W.
    Mermin, Jonathan
    Salomon, Joshua A.
    Linas, Benjamin P.
    CLINICAL INFECTIOUS DISEASES, 2018, 67 (04) : 549 - 556
  • [3] Chronic hepatitis C virus (HCV) disease burden and cost in the United States
    Razavi, Homie
    ElKhoury, Antoine C.
    Elbasha, Elamin
    Estes, Chris
    Pasini, Ken
    Poynard, Thierry
    Kumar, Ritesh
    HEPATOLOGY, 2013, 57 (06) : 2164 - 2170
  • [4] HEALTHCARE COSTS BY STAGE OF LIVER DISEASE IN CHRONIC HEPATITIS C PATIENTS IN THE UNITED STATES
    Walker, D. R.
    Manthena, S. R.
    Juday, T. R.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S593 - S594
  • [5] The Cost of Making Hepatitis C a Rare Disease in the United States
    Chhatwal, Jagpreet
    Wang, Xiaojie
    Roberts, Mark S.
    Kabiri, Mina
    Ayer, Turgay
    Donohue, Julie M.
    Kanwal, Fasiha
    HEPATOLOGY, 2015, 62 : 285A - 286A
  • [6] SYSTEMATIC LITERATURE REVIEW TO IDENTIFY COST ESTIMATES OF LIVER DISEASE IN THOSE WITH CHRONIC HEPATITIS C VIRUS (HCV) IN THE UNITED STATES
    Mauskopf, J. A.
    Mitchell, S.
    Samuel, M.
    Samp, J. C.
    VALUE IN HEALTH, 2015, 18 (03) : A236 - A236
  • [7] Metabolic Phenotyping for Enhanced Mechanistic Stratification of Chronic Hepatitis C-Induced Liver Fibrosis
    Sands, Caroline J.
    Guha, Indra N.
    Kyriakides, Michael
    Wright, Mark
    Beckonert, Olaf
    Holmes, Elaine
    Rosenberg, William M.
    Coen, Muireann
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 (01): : 159 - 169
  • [8] Prevalence and clinical consequences of Hepatitis E in patients who underwent liver transplantation for chronic Hepatitis C in the United States
    Koning, Ludi
    Charlton, Michael R.
    Pas, Suzan D.
    Heimbach, Julie K.
    Osterhaus, Albert D. M. E.
    Watt, Kymberly D.
    Janssen, Harry L. A.
    de Knegt, Robert J.
    van der Eijk, Annemiek A.
    BMC INFECTIOUS DISEASES, 2015, 15
  • [9] Prevalence and clinical consequences of Hepatitis E in patients who underwent liver transplantation for chronic Hepatitis C in the United States
    Ludi Koning
    Michael R. Charlton
    Suzan D. Pas
    Julie K. Heimbach
    Albert DME Osterhaus
    Kymberly D. Watt
    Harry LA Janssen
    Robert J. de Knegt
    Annemiek A. van der Eijk
    BMC Infectious Diseases, 15
  • [10] Immune Response to Extracellular Matrix Collagen in Chronic Hepatitis C-Induced Liver Fibrosis
    Borg, Brian B.
    Seetharam, Anil
    Subramanian, Vijay
    Basha, Haseeb Ilias
    Lisker-Melman, Mauricio
    Korenblat, Kevin
    Anderson, Christopher D.
    Shenoy, Surendra
    Chapman, William C.
    Crippin, Jeffrey S.
    Mohanakumar, Thalachallour
    LIVER TRANSPLANTATION, 2011, 17 (07) : 814 - 823
12345